A Michigan panel is reviewing the state’s medical marijuana law and deciding whether certain conditions qualify for the program. On Tuesday the panel gave preliminary approval to post-traumatic stress disorder, but rejected petitions to add autism, insomnia, and asthma.
"In my opinion, marijuana is one of the best medications for people with PTSD," said appointee David Crocker, a medical doctor from Kalamazoo.
“We have a lot of veterans with PTSD in our clinics. Many of them will tell you they think marijuana saved their lives, and many of their families will tell you the same thing."
The panel voted 7 to 2 to approve PTSD.
A public hearing is scheduled to be held within 60 days, before the panel reconvenes for a final vote. The final say on qualified condition belongs to the Michigan Department of Licensing and Regulatory Affairs, the agency which appointed the panel and will administer the medical marijuana program.
Insomnia will be revisited at the public hearing and given another vote. Autism and asthma however were considered final decisions because they were considered by a previous panel.